Pharmacological inhibition of histone acetylation reduced the levels of DREAM in explanted SSc fibroblasts, suggesting epigenetic mechanisms accounting for cell-autonomous dysregulation of A20 in SSc. The gene discussed is KCNIP3; the disease is systemic sclerosis.